TMED vs. TBUX
TMED (T. Rowe Price Health Care ETF) and TBUX (T. Rowe Price Ultra Short-Term Bond ETF) are both exchange-traded funds - TMED is a Health & Biotech Equities fund managed by T. Rowe Price, while TBUX is a Ultrashort Bond fund actively managed by T. Rowe Price. At a 0.12 correlation, their price movements are largely independent. TMED charges 0.44%/yr vs 0.17%/yr for TBUX.
Performance
TMED vs. TBUX - Performance Comparison
Loading charts...
Returns By Period
In the year-to-date period, TMED achieves a 3.87% return, which is significantly higher than TBUX's 1.65% return.
TMED
- 1D
- 1.04%
- 1M
- 2.47%
- YTD
- 3.87%
- 6M
- 4.17%
- 1Y
- —
- 3Y*
- —
- 5Y*
- —
- 10Y*
- —
TBUX
- 1D
- -0.04%
- 1M
- 0.41%
- YTD
- 1.65%
- 6M
- 2.09%
- 1Y
- 4.77%
- 3Y*
- 5.85%
- 5Y*
- —
- 10Y*
- —
TMED vs. TBUX - Yearly Performance Comparison
| 2026 (YTD) | 2025 | |
|---|---|---|
TMED T. Rowe Price Health Care ETF | 3.87% | 18.92% |
TBUX T. Rowe Price Ultra Short-Term Bond ETF | 1.65% | 2.92% |
Correlation
The correlation between TMED and TBUX is 0.12, which is low. Their price movements are largely independent, making them effective diversification partners.
| Correlation | |
|---|---|
Correlation (All Time) Calculated using the full available price history since Jun 13, 2025 | 0.12 |
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Return for Risk
TMED vs. TBUX — Risk / Return Rank
TMED
TBUX
TMED vs. TBUX - Risk-Adjusted Trends Comparison
This table presents a comparison of risk-adjusted performance metrics for T. Rowe Price Health Care ETF (TMED) and T. Rowe Price Ultra Short-Term Bond ETF (TBUX). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
Risk / return metrics aren't available yet — we need at least 12 months of trading data to calculate them.
Loading charts...
Sharpe Ratios by Period
| TMED | TBUX | Difference | |
|---|---|---|---|
Sharpe Ratio (1Y)Calculated over the trailing 1-year period | — | 7.13 | — |
Sharpe Ratio (All Time)Calculated using the full available price history | 1.35 | 3.89 | -2.53 |
Drawdowns
TMED vs. TBUX - Drawdown Comparison
The maximum TMED drawdown since its inception was -11.11%, which is greater than TBUX's maximum drawdown of -1.79%. Use the drawdown chart below to compare losses from any high point for TMED and TBUX.
Loading charts...
Drawdown Indicators
| TMED | TBUX | Difference | |
|---|---|---|---|
Max DrawdownLargest peak-to-trough decline | -11.11% | -1.79% | -9.32% |
Max Drawdown (1Y)Largest decline over 1 year | — | -0.12% | — |
Max Drawdown (3Y)Largest decline over 3 years | — | -0.33% | — |
Current DrawdownCurrent decline from peak | -2.75% | -0.04% | -2.71% |
Average DrawdownAverage peak-to-trough decline | -2.59% | -0.28% | -2.31% |
Ulcer IndexDepth and duration of drawdowns from previous peaks | — | 0.03% | — |
Volatility
TMED vs. TBUX - Volatility Comparison
Loading charts...
Volatility by Period
| TMED | TBUX | Difference | |
|---|---|---|---|
Volatility (1M)Calculated over the trailing 1-month period | — | 0.19% | — |
Volatility (6M)Calculated over the trailing 6-month period | — | 0.43% | — |
Volatility (1Y)Calculated over the trailing 1-year period | 18.04% | 0.67% | +17.37% |
Volatility (5Y)Calculated over the trailing 5-year period, annualized | 18.04% | 1.07% | +16.97% |
Volatility (10Y)Calculated over the trailing 10-year period, annualized | 18.04% | 1.07% | +16.97% |
TMED vs. TBUX - Expense Ratio Comparison
TMED has a 0.44% expense ratio, which is higher than TBUX's 0.17% expense ratio.
Dividends
TMED vs. TBUX - Dividend Comparison
TMED's dividend yield for the trailing twelve months is around 0.52%, less than TBUX's 4.48% yield.
| Position | TTM | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|---|
TBUX T. Rowe Price Ultra Short-Term Bond ETF | 4.48% | 4.67% | 5.39% | 4.66% | 2.58% | 0.27% |
TMED T. Rowe Price Health Care ETF | 0.52% | 0.54% | 0.00% | 0.00% | 0.00% | 0.00% |
Frequently Asked Questions
TMED and TBUX have a correlation of 0.12, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.
On fees, TBUX is cheaper at 0.17% per year. The better choice depends on whether you care most about return, fees, risk, or income.
TBUX is cheaper with a 0.17% expense ratio, compared with 0.44% for TMED.
TBUX has the higher dividend yield at 4.48%, compared with 0.52% for TMED.
TMED is categorized as Health & Biotech Equities, while TBUX is Ultrashort Bond. Their fees differ too: 0.44% for TMED and 0.17% for TBUX.
Find the right allocation for TMED and TBUX
Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.
Open Portfolio Optimizer